The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Auron Therapeutics
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bayer; BioLineRx; Celgene; Daiichi Sankyo; Novartis; Pfizer; PTC Therapeutics; Syros Pharmaceuticals
Research Funding - Agios; Amgen; Bayer; Celgene; Syros Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Novartis; Syros Pharmaceuticals
Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML).
 
Courtney Denton Dinardo
Honoraria - Abbvie; Agios; Bayer; Celgene; Karyopharm Therapeutics; MedImmune
Consulting or Advisory Role - Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Anthony Selwyn Stein
Speakers' Bureau - Amgen; Celgene; Stemline Therapeutics
 
Eytan M. Stein
No Relationships to Disclose
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
Olga Frankfurt
Consulting or Advisory Role - Agios; Celgene; Jazz Pharmaceuticals
Speakers' Bureau - Agios; Celgene; Jazz Pharmaceuticals
 
Andre C. Schuh
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Shire
Consulting or Advisory Role - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Shire
Research Funding - Agios (Inst); Amgen (Inst); Celgene (Inst); Janssen (Inst); Pfizer (Inst); Shire (Inst)
 
Giovanni Martinelli
Consulting or Advisory Role - ARIAD; Celgene; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Prapti Arvind Patel
Honoraria - DAVA Pharmaceuticals; France Foundation
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
 
Emmanuel Raffoux
No Relationships to Disclose
 
Peter Tan
Research Funding - Agios (Inst); Janssen (Inst); NOHLA Therapeutics (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; ARIAD; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Cardinal Health; Celgene; Daiichi Sankyo; Incyte; Novartis; Otsuka; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; ARIAD; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Cardinal Health; Celgene; Daiichi Sankyo; Incyte; Novartis; Otsuka; Pfizer; Seagen; Takeda
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); ADC Therapeutics (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Incyte (Inst); MedImmune (Inst); Otsuka (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
 
Stéphane de Botton
Honoraria - Abbvie; Agios; Bayer; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
Consulting or Advisory Role - Agios; Bayer; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
Speakers' Bureau - Abbvie
Research Funding - Agios
Travel, Accommodations, Expenses - Agios; Carthagenetics; Celgene; FORMA Therapeutics; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst)
 
Richard M. Stone
Honoraria - DAVA Pharmaceuticals; Medscape; Prime Oncology; Research to Practice
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; argenx; Arog; Astellas Pharma; AstraZeneca; Celgene; Celgene/Jazz; Cornerstone Pharmaceuticals; Macrogenics; Novartis; Otsuka; Pfizer; Roche/Genentech; Stemline Therapeutics; Takeda
Research Funding - Abbvie/Genentech (Inst); Agios (Inst); Novartis (Inst)
 
Du Hung Lam
Employment - Celgene; Novartis; Pfizer
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
 
Jing Gong
Employment - Celgene
 
Vickie Zhang
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Thomas Winkler
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Bin Wu
Employment - Agios
Stock and Other Ownership Interests - Agios
Patents, Royalties, Other Intellectual Property - Agios
Travel, Accommodations, Expenses - Agios
 
Paresh Vyas
No Relationships to Disclose